Laboratoire de Biologie Cellulaire du Vieillissement, UR4-IFR83, Université Pierre et Marie Curie–Paris 6, 4 place Jussieu, Paris Cedex 05, France.
Prog Mol Biol Transl Sci. 2012;109:249-75. doi: 10.1016/B978-0-12-397863-9.00007-9.
Accumulation of oxidized and damaged proteins is a hallmark of the aging process in different organs and tissues. Intracellular protein degradation is normally the most efficient mechanism to prevent toxicity associated with the accumulation of altered proteins without affecting the cellular reserves of amino acids. Protein degradation by the proteasomal system is a key process for the maintenance of cellular protein homeostasis and has come into the focus of aging research during the last decade. During the last few years, several lines of evidence have indicated that proteasome function is impaired during aging, suggesting that this decreased activity might be causally related to the aging process and the occurrence of age-associated diseases. This chapter reviews the proteasome status in organs, tissues, cells, and model organisms during aging as well as the molecular mechanisms involved in the age-related decline of proteasome function. Finally, interventions aimed at rejuvenating proteasome function as a potential antiaging strategy are discussed.
氧化和受损蛋白质的积累是不同器官和组织衰老过程的一个标志。细胞内蛋白质降解通常是防止与改变的蛋白质积累相关的毒性的最有效机制,而不会影响氨基酸的细胞储备。蛋白酶体系统的蛋白质降解是维持细胞蛋白质内稳态的关键过程,在过去十年中已成为衰老研究的焦点。在过去的几年中,有几条证据表明蛋白酶体功能在衰老过程中受损,这表明这种活性降低可能与衰老过程和与年龄相关的疾病的发生有因果关系。本章综述了衰老过程中器官、组织、细胞和模式生物中的蛋白酶体状态,以及与蛋白酶体功能随年龄下降相关的分子机制。最后,讨论了旨在恢复蛋白酶体功能作为潜在抗衰老策略的干预措施。